Synthesis, characterized, QSAR studies and molecular docking of some phosphonates as COVID-19 inhibitors.

ABSTRACT: The global coronavirus (COVID-19) outbreak has prompted scientists to discover a cure for the disease. So far, phosphorus-based drugs have been proposed. These drugs have good inhibitory activity against the main protease (Mpro). Hence, in order to introduce a group of inhibitors the coronavirus, 51 compounds containing different mono, bis, and tetra phosphonates as Remdesivir derivatives, 32 of which are new, were synthesized and characterized by ³¹P, ¹³C, and ¹H NMR and IR spectroscopy. Their biological activities were also investigated by Molecular Docking, QSAR, and Pharmacophore. Van der Waals, hydrogen bonding, and hydrophobic interactions were studied for all compounds as well as binding energy (△G, Kcal/mole) and the inhibitory constant Ki (μM) obta

SUBMITTER: Gholivand K 

PROVIDER: S-EPMC8978535 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature